Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cerilliant
US Department of Justice
US Army
Baxter
Citi
Queensland Health
AstraZeneca
Accenture

Generated: May 23, 2018

DrugPatentWatch Database Preview

POTIGA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Potiga, and what generic alternatives are available?

Potiga is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in POTIGA is ezogabine. One supplier is listed for this compound. Additional details are available on the ezogabine profile page.
Drug patent expirations by year for POTIGA
Pharmacology for POTIGA
Synonyms for POTIGA
[2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester
[2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamate
12G01I6BBU
150812-12-7
2-AMINO-4-(4-FLUORBENZYLAMINO)-1-ETHOXYCARBONYLAMINOBENZENE
812R127
A809076
AB0035830
AC-6908
AC1L3TLD
ADD-230001
AJ-08384
AKOS015895311
AN-6616
API0004057
AW21-360
AWD-21360
AWD21-360
B5888
BC210476
BCP0726000089
BDBM50143558
C13826
C16H18FN3O2
Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester
CHEBI:68584
CHEMBL41355
CS-0990
CTK8E8130
D 20443
D 23129
D-20443
D-23129
D09569
D0X7GL
D23129
DB04953
DEA No. 2779
DR001230
DTXSID40164615
Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate
ethyl (2-amino-4-((4-fluorobenzyl)amino)phenyl)carbamate
Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate
ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate
Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate
ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride
ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate
ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate
EZG
Ezogabine
Ezogabine (USAN)
Ezogabine [USAN]
FT-0080801
FT-0601527
GKE-841
GKI 841
GP5601
GTPL2601
GW 582892X
GW-582892X
GW582892X
HSDB 8171
HY-15471
I06-0810
KE 841
KE-0201
KS-000007VJ
LS-48932
MFCD04307735
MolPort-003-850-148
N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester
N-(2-amino-4-(4-fluorobenzylamino)-phenyl)carbamic acid ethylester
N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
N-(2-amino-4-[fluorobenzylamino]-phenyl) carbamic acid|D-23129
N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamic acid ethyl ester
N03AX21
NCGC00346739-01
OR223992
PCOBBVZJEWWZFR-UHFFFAOYSA-N
Potiga (TN)
Potiva
Q-101418
QC-1587
Retigabine
Retigabine (INN)
Retigabine [INN]
Retigabine [USAN]
Retigabine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material
Retigabine, >=98% (HPLC)
Retigabine, analytical standard
Retigabine,D2312, D-23129
RetigabineSee also: R189051 (HCl salt)
RL01925
RT-015392
RTG
S-7700
s4733
SC-23393
SCHEMBL20835
TL80090034
Trobalt
UNII-12G01I6BBU
WAY 143841
WAY-143841
Y0237
ZB000739
ZINC00016154
ZINC16154

US Patents and Regulatory Information for POTIGA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-001 Jun 10, 2011 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-004 Jun 10, 2011 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-002 Jun 10, 2011 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline POTIGA ezogabine TABLET;ORAL 022345-003 Jun 10, 2011 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chubb
Covington
Moodys
Healthtrust
Cipla
Boehringer Ingelheim
Chinese Patent Office
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.